Image below from Healius FY22 presentation. non-covid revenue was down on FY21.
Image below from ACL FY22 presentation. Non-covid revenue up 8% on FY21.
Market overreacting on HLS poor result. Obviously ACL wont produce the revenue & profits it did in FY22 but i think this is baked into the price & should pop on 1HY results. Let's see!!
Image below from Healius FY22 presentation. non-covid revenue...
Add ACL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.59 |
Change
0.130(5.28%) |
Mkt cap ! $522.7M | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.61 | $2.46 | $1.728M | 671.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2411 | $2.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.61 | 18419 | 5 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| ACL (ASX) Chart |